Your browser doesn't support javascript.
loading
Combined Photon and Carbon Ion Radiation Therapy for Sinonasal Malignancies: Results of the HIT-SNT Prospective Phase 2 Trial.
Weusthof, Katharina; Held, Thomas; Lang, Kristin; Rachel, Zoe E; Harrabi, Semi B; Plath, Karim; Freudlsperger, Christian; Herfarth, Klaus; Debus, Jürgen; Haberer, Thomas; Münter, Marc; Jensen, Alexandra D; Adeberg, Sebastian.
Affiliation
  • Weusthof K; National Center for Tumor Disease (NCT), University Hospital Heidelberg (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Radiation Oncology, University Hospital Heidelberg (UKHD), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany. E
  • Held T; National Center for Tumor Disease (NCT), University Hospital Heidelberg (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Radiation Oncology, University Hospital Heidelberg (UKHD), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany.
  • Lang K; National Center for Tumor Disease (NCT), University Hospital Heidelberg (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Radiation Oncology, University Hospital Heidelberg (UKHD), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany.
  • Rachel ZE; Department of Radiation Oncology, University Hospital Heidelberg (UKHD), Heidelberg, Germany.
  • Harrabi SB; National Center for Tumor Disease (NCT), University Hospital Heidelberg (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Radiation Oncology, University Hospital Heidelberg (UKHD), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany.
  • Plath K; Departments of Otorhinolaryngology and.
  • Freudlsperger C; Oral and Maxillofacial Surgery, University Hospital Heidelberg (UKHD), Heidelberg, Germany.
  • Herfarth K; National Center for Tumor Disease (NCT), University Hospital Heidelberg (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany.
  • Debus J; National Center for Tumor Disease (NCT), University Hospital Heidelberg (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Radiation Oncology, University Hospital Heidelberg (UKHD), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany.
  • Haberer T; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany.
  • Münter M; Department of Radiation Oncology, Klinikum Stuttgart, Stuttgart, Germany.
  • Jensen AD; Department of Radiation Oncology, Klinikum Fulda, Fulda, Germany.
  • Adeberg S; National Center for Tumor Disease (NCT), University Hospital Heidelberg (UKHD) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Radiation Oncology, University Hospital Heidelberg (UKHD), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany; D
Int J Radiat Oncol Biol Phys ; 118(5): 1563-1574, 2024 Apr 01.
Article in En | MEDLINE | ID: mdl-37866761
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Radiotherapy, Intensity-Modulated / Heavy Ion Radiotherapy Limits: Humans Language: En Journal: Int J Radiat Oncol Biol Phys Year: 2024 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Radiotherapy, Intensity-Modulated / Heavy Ion Radiotherapy Limits: Humans Language: En Journal: Int J Radiat Oncol Biol Phys Year: 2024 Document type: Article Country of publication: United States